Review of GLP-1 drug use in perioperative settings covers preoperative management, anesthesia considerations, aspiration risk, and postoperative glycemic control.
Key findingReview of GLP-1 drug use in perioperative settings covers preoperative management, anesthesia consid
What the researchers found
Review of GLP-1 drug use in perioperative settings covers preoperative management, anesthesia considerations, aspiration risk, and postoperative glycemic control.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
Single patient case; specific gastric volume not detailed in abstract.
How the study worked
In publication.
Who was studied
Single adult patient on GLP-1 receptor agonist undergoing surgery
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Perioperative Period: A Case Study.
Cureus, 17(1), e77106
Citation
Anderson, Todd R; Bushhouse, Mark; Carletto, Emily J; Holder, Kelly. (2025). The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Perioperative Period: A Case Study.. Cureus, 17(1), e77106. https://doi.org/10.7759/cureus.77106